Options: Show MedDRA Preferred Terms, display all 23 labels
Information about indications was extracted from the indications and usage sections of the labels.
Indication | Labels | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Asthma | x | |||||||||||||||||||||
Bone cancer metastatic | x | x | x | x | ||||||||||||||||||
Bone disorder | x | x | ||||||||||||||||||||
Bone mass decreased | x | x | x | |||||||||||||||||||
Breast cancer | x | x | x | x | x | |||||||||||||||||
Dyspepsia | x | x | x | x | x | x | x | x | ||||||||||||||
Fracture | x | x | x | x | x | x | x | x | x | x | x | x | x | |||||||||
Gastrointestinal disorder | x | x | x | x | x | x | x | x | x | x | x | x | ||||||||||
Hypercalcaemia | x | x | x | |||||||||||||||||||
Metastasis | x | x | x | |||||||||||||||||||
Neoplasm | x | x | x | |||||||||||||||||||
Neoplasm malignant | x | x | x | x | x | |||||||||||||||||
Osteoporosis | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | |||
Osteoporosis postmenopausal | x | x | x | x | x | x | x | x | x | x | x | x | x | x | ||||||||
Osteoporotic fracture | x | x | x | |||||||||||||||||||
Peptic ulcer | x | x |
standard – alternative
100% | ||
75% | ||
50% | ||
10% | ||
frequent (1% to 100%) | ||
infrequent (0.1% to 1%) | ||
rare (<0.1%) | ||
postmarketing | ||
0% | ||
no frequency information | ||
not found on label |